Management tracks: Five Prime, CytoSen

Cancer play Five Prime Therapeutics Inc. (NASDAQ:FPRX) promoted Aron Knickerbocker to president and CEO from COO, effective Jan. 1, 2018. He succeeds Lewis Williams, who will

Read the full 267 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE